Safety in Pregnancy
15 results
Applied filters
Aspirin tablets for use within antenatal and maternity services
18 December 2025SPS PGD template for the supply of aspirin tablets to individuals at risk of pre-eclampsia during pregnancy.
Conducting a medicines risk assessment in pregnancy
15 July 2025The questions asked should provide information on factors that are critical to the risk assessment for each individual pregnancy.
Considerations and interactions with GLP-1 receptor agonists
12 November 2025Signposting key risks and interactions of GLP-1 receptor agonists in diabetes, obesity, and weight management.
Folic acid 5mg tablets for use during pregnancy
11 November 2025SPS PGD template for the supply of folic acid 5mg tablets to reduce risk of neural tube defect or compensate for increased folate demand during pregnancy.
Haemorrhoids: treatment during pregnancy
4 March 2025Use non-pharmacological treatment for the management of haemorrhoids during pregnancy. If insufficient use a topical haemorrhoidal preparation.
Hay fever or allergic rhinitis: treatment during pregnancy
31 January 2025Use non-pharmacological treatments for the initial management of hay fever during pregnancy. If insufficient, use topical treatments or oral antihistamines.
Information resources for advice about medicines in pregnancy
15 July 2025SPS and other resources can help pharmacy and other healthcare professionals provide advice on medicines in pregnancy.
Intrapartum administration of benzylpenicillin sodium
23 December 2025SPS PGD template for intrapartum administration of benzylpenicillin sodium for prevention of early-onset Group B Streptococcus (GBS) neonatal infection
Omeprazole for use within antenatal and maternity services
22 December 2025SPS protocol templates for the supply and administration of omeprazole for caesarean section by registered midwives.
Pain: treatment during pregnancy
3 April 2025A summary of pharmacological options commonly used to treat pain in primary care.